Evaluation of MK-870: a new potassium-sparing diuretic.
作者信息
Singh B N, Richmond D E, Wilson J D, Simmonds H A, North J D
出版信息
Br Med J. 1967 Jan 21;1(5533):143-6. doi: 10.1136/bmj.1.5533.143.
Abstract
摘要
相似文献
1
Evaluation of MK-870: a new potassium-sparing diuretic.MK-870的评估：一种新型保钾利尿剂。
Br Med J. 1967 Jan 21;1(5533):143-6. doi: 10.1136/bmj.1.5533.143.
2
Clinical evaluation of amiloride, a potassium-sparing diuretic.氨氯吡咪（一种保钾利尿剂）的临床评估。
Clin Pharmacol Ther. 1969 Jan-Feb;10(1):50-63. doi: 10.1002/cpt196910150.
3
[Clinical effect of a new saluretic drug: ethacrynic acid].一种新型利尿药：依他尼酸的临床疗效
Minerva Nefrol. 1968 Jul-Aug;15(4):245-52.
4
[Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
Minerva Nefrol. 1968 Jul-Aug;15(4):258-60.
5
Treatment of edema with amiloride alone and in combination with hydrochlorothiazide, chlorothiazide and ethacrynic acid.单独使用阿米洛利以及联合使用氢氯噻嗪、氯噻嗪和依他尼酸治疗水肿。
Isr J Med Sci. 1970 Jan-Feb;6(1):156-60.
6
A clinical comparison of ethacrynic acid, hydrochlorothiazide, and triamterene by permutation trial.依他尼酸、氢氯噻嗪和氨苯蝶啶的置换试验临床比较
J Clin Pharmacol J New Drugs. 1968 Mar-Apr;8(2):118-25. doi: 10.1002/j.1552-4604.1968.tb00257.x.
7
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.高剂量螺内酯（安体舒通、SC - 14266、维螺酮）单独使用以及与氨苯蝶啶和/或利尿剂联合使用治疗与继发性醛固酮增多症相关的难治性水肿。
Endokrinologie. 1970;57(1):46-62.
8
[Physiological principles of diuretic therapy].[利尿治疗的生理原理]
Vnitr Lek. 1970 Sep;16(9):868-76.
9
Renal function and diuretic therapy in infants and children. Part III.
J Pediatr. 1975 Jun;86(6):825-32. doi: 10.1016/s0022-3476(75)80210-1.
10
[Diuresis with edecrin].
Wien Med Wochenschr. 1968 Apr 20;118(16):370-3.
引用本文的文献
1
Combination of Diuretics in States of Resistant Nephrotic Edema: a Case Presentation.顽固性肾病性水肿状态下利尿剂的联合应用：病例报告
Maedica (Bucur). 2024 Sep;19(3):641-647. doi: 10.26574/maedica.2024.19.3.641.
2
Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches.肾病综合征：从病理生理学到新型治疗方法
Biomedicines. 2024 Mar 3;12(3):569. doi: 10.3390/biomedicines12030569.
3
Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.替尼酸和氨氯吡咪对健康志愿者及肾功能正常的高血压患者的影响。
Br J Clin Pharmacol. 1980 Oct;10(4):345-51. doi: 10.1111/j.1365-2125.1980.tb01770.x.
4
The mechanism of action of amipramizide.阿米普明的作用机制。
Pflugers Arch. 1968;302(1):79-96. doi: 10.1007/BF00586783.
5
[The effectivness of ethacrynic acid, amiloride HCl and aldadiene K in kidney insufficiency].
Klin Wochenschr. 1970 Apr 15;48(8):471-80. doi: 10.1007/BF01485097.
6
The use of amiloride hydrochloride in the correction of hypokalaemic alkalosis induced by diuretics.盐酸阿米洛利在纠正利尿剂所致低钾性碱中毒中的应用。
Postgrad Med J. 1971 Oct;47(552):644-7. doi: 10.1136/pgmj.47.552.644.
7
Diuretics. I. Physiological and pharmacological considerations.利尿剂。一、生理学和药理学考量。
Drugs. 1971;1(1):54-81. doi: 10.2165/00003495-197101010-00004.
8
The treatment of heart failure. A methodological review of the literature.
Drugs. 1986 Dec;32(6):538-68. doi: 10.2165/00003495-198632060-00004.
9
The effect of amiloride on the transepithelial potential difference of the distal tubule of the rat kidney.阿米洛利对大鼠肾脏远曲小管跨上皮电位差的影响。
Pflugers Arch. 1976 Feb 24;361(3):251-4. doi: 10.1007/BF00587289.
10
Long term effect of timolol and hydrochlorothiazide, or hydrochlorothiazide and amiloride, in essential hypertension.噻吗洛尔与氢氯噻嗪或氢氯噻嗪与阿米洛利治疗原发性高血压的长期疗效
Eur J Clin Pharmacol. 1977 Oct 14;12(2):97-103. doi: 10.1007/BF00645129.
本文引用的文献
1
Endogenous creatinine in serum and urine.血清和尿液中的内源性肌酐。
Proc Soc Exp Biol Med. 1950 May;74(1):148-51. doi: 10.3181/00379727-74-17837.
2
THE TREATMENT OF CHRONIC RENAL FAILURE BY A MODIFIED GIOVANNETTI DIET.改良乔瓦内蒂饮食疗法治疗慢性肾功能衰竭
Q J Med. 1965 Apr;34:237-53.
3
CORRECTION OF DIURETIC-INDUCED HYPOKALEMIA AND HYPERURICEMIA.利尿剂所致低钾血症和高尿酸血症的纠正
Am J Med Sci. 1965 Mar;249:269-72. doi: 10.1097/00000441-196503000-00003.
4
METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES.肝硬化腹水患者使用利尿药氨苯蝶啶的代谢研究
N Engl J Med. 1964 Dec 10;271:1229-35. doi: 10.1056/NEJM196412102712402.
5
SMALL-BOWEL ULCERATION APPARENTLY ASSOCIATED WITH THIAZIDE AND POTASSIUM THERAPY.明显与噻嗪类及钾治疗相关的小肠溃疡
JAMA. 1964 Nov 16;190:586-90. doi: 10.1001/jama.1964.03070200022005.
6
CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE.新型利尿剂氨苯蝶啶治疗充血性心力衰竭的临床经验
Can Med Assoc J. 1964 Aug 15;91(7):315-8.
7
Use of a pteridine diuretic (tri-amterene) in treatment of hepatic ascites.使用蝶啶类利尿剂（氨苯蝶啶）治疗肝腹水。
Br Med J. 1962 Sep 22;2(5307):764-7. doi: 10.1136/bmj.2.5307.764.
8
Clinical trial of new oral diuretic-SKF 8542.新型口服利尿剂SKF 8542的临床试验
Lancet. 1962 Feb 3;1(7223):245-7. doi: 10.1016/s0140-6736(62)91192-3.
9
Triamterene, a new diuretic drug. II. Clinical trial in oedematous patients.氨苯蝶啶，一种新型利尿药。II. 水肿患者的临床试验。
Br Med J. 1962 Sep 22;2(5307):760-4. doi: 10.1136/bmj.2.5307.760.
10
MK 870: a new potassium-sparing diuretic.MK 870：一种新型保钾利尿剂。
N Z Med J. 1966 Aug;65(408):505-11.
Zotero 插件